Successful treatment of cutaneous leishmaniasis unresponsive to conventional drugs with itraconazole
DOI:
https://doi.org/10.66344/jpad.32.2.2022.1889Abstract
Leishmaniasis is a disease caused by a parasite of Leishmania Genus, transmitted by prick of an infected sandfly. The disease presents clinically with cutaneous, mucocutaneous or visceral form, depending upon the type of infective species and the immune status of the person. Antimonial drugs are first line of treatment for all clinical forms. Amphotericin B is second choice drug. We report a young male with cutaneous leishmaniasis unresponsive to conventional drugs successfully treated with itraconazole.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Tauseef Kamran
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
